From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction.

A new study published in the Journal of Cosmetic Dermatology revealed that dermatologic benefits of topical omega-3 ...

Roflumilast 0.3% cream (Zoryve), a phosphodiesterase-4 inhibitor, was approved in July 2022 for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age and ...

Inverse psoriasis, which causes painful lesions on sensitive skin folds, can be hard to treat. Find out more about this type of psoriasis.

Other formulations of Zoryve include roflumilast cream 0.3% for the topical treatment of plaque psoriasis, including intertriginous areas; and roflumilast cream 0.15% for the topical treatment of ...

Session ID: 2025-07-04:9426c64654ca7cd4f0d9745f Player Element ID: Va0cc0e01_e574_44c4_9c37_dba120bd3b5e_6347850733112 ...

Researchers develop nanofiber patch for treatment of psoriasis Date: November 12, 2024 Source: University of Copenhagen - The Faculty of Health and Medical Sciences Summary: Researchers have ...

In this video, Ahmad Shatil Amin, MD, medical practice director at the Northwestern Medicine Dermatology, discusses the latest treatment options for psoriasis.

If you’re one of the 7.5 million people in the U.S. with psoriasis, 1 you know how important it is to find the best treatment for you. And you’re probably well aware that the road to psoriasis ...

"Psoriatic arthritis can develop in about 30% of individuals with psoriasis," Emerson said. It's important to get treatment for both conditions to prevent rashes and to protect overall health.

Dr Pourzand believes a drug targeting hepcidin has the potential to dramatically improve treatment options for all psoriasis patients. She said: "Our data strongly suggests hepcidin would be a ...